MCLNG - Overview: MayoComplete Lung Cancer-Targeted Gene Panel with Rearrangement, Tumor
Diagnosis and management of patients with lung cancer Assessing microsatellite instability
AVWPR - Overview: von Willebrand Disease Profile, Plasma
Detection of deficiency or abnormality of von Willebrand factor (VWF) and related deficiency of factor VIII coagulant activity Subtyping von Willebrand disease (VWD) as type 1 (most common), type 2 variants (less common), or type 3...
CJDEI - Overview: Creutzfeldt-Jakob Disease Evaluation Interpretation, Spinal Fluid
Interpretation of the Creutzfeldt-Jakob Disease Evaluation
TGQN - Overview: Thyroglobulin, Tumor Marker, Serum
Quantitative thyroglobulin measurement as a part of evaluating suspected interference from heterophile antibodies causing a falsely elevated thyroglobulin result
UPGDW - Overview: Uroporphyrinogen Decarboxylase, Washed Erythrocytes
Diagnosis of porphyria cutanea tarda type II and hepatoerythropoietic porphyria
UPGD - Overview: Uroporphyrinogen Decarboxylase, Whole Blood
Preferred test for the confirmation of a diagnosis of porphyria cutanea tarda type II and hepatoerythropoietic porphyria
HMUOE - Overview: Heavy Metal Occupational Exposure, with Reflex, Random, Urine
Preferred screening test for detection of arsenic, cadmium, mercury, and lead due to occupational exposure using random urine specimens
G6PDC - Overview: Glucose 6 Phosphate Dehydrogenase Enzyme Activity, Blood
Evaluation of individuals with episodic or chronic Coombs-negative nonspherocytic hemolytic anemia Rapid testing to assess glucose-6-phosphate dehydrogenase (G6PD) enzyme capacity prior to rasburicase or other therapies that may cause...
HMUCR - Overview: Heavy Metal/Creatinine Ratio, with Reflex, Random, Urine
Preferred screening test for detection of arsenic, cadmium, mercury, and lead in random urine specimens
RAVU - Overview: Ravulizumab, Serum
Assessing the response to ravulizumab therapy Assessing the need for dose escalation Evaluating the potential for dose deescalation or discontinuation of therapy in remission states Monitoring patients who need to be above a certain...
Register today for Classical Hematology 2023 - Insights
Taking place on October 3–4, 2023, in Rochester, Minnesota, the Classical Hematology 2023 conference focuses on addressing the evaluation of frequently encountered blood count abnormalities. The conference...
Top 5 Mayo Clinic Laboratories advancements in 2024 - Insights
Five of the most significant advancements from Mayo Clinic Laboratories in 2024 to enhance diagnostics and patient care globally....
Visit Mayo Clinic Laboratories at Medlab Middle East 2023 - Insights
announce our participation in Medlab Middle East 2023, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 6–9, 2023....
Visit Mayo Clinic Laboratories at Medlab Middle East 2024 - Insights
announce our participation in Medlab Middle East 2024, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 5–8, 2024....
Managing Compliance in Preparation for 2025 Updates - Insights
With updates expected to federal compliance guidance for laboratories in 2025, now is a great time to revisit existing guidelines and plans....